Abstract:Introduction The HPV-Automated Visual Evaluation (PAVE) Study is an international, multi-centric study designed to evaluate a novel cervical screen-triage-treat strategy for resource-limited settings as part of a global strategy to reduce cervical cancer burden as part of the National Cancer Institute's Cancer Cures Moonshot Initiative. The PAVE strategy involves: 1) screening with self-sampled HPV testing; 2) triage of HPV-positive participants with a combination of extended genotyping and visual evaluation of the cervix assisted by deep-learning-based automated visual evaluation (AVE); and 3) treatment with thermal ablation or excision (LLETZ). The PAVE study has two phases: efficacy (2023-2024) and effectiveness (planned to begin in 2024-2025). The efficacy phase aims to refine and validate the screen-triage portion of the protocol. The effectiveness phase will examine implementation of the PAVE strategy into clinical practice, cost-effectiveness, and health communication. The study will enroll a total 100,000 women in 9 different countries. Objective The Cambodia section of the study will enroll a total of 10,000 women 25 to 49 years of age. Two different cohorts are being studied: lower-risk women who are employed (and screened) at garment factories, and higher-risk women living with HIV (WLWH) who are enrolled in the Cambodian National Centre for HIV/AIDS Dermatology and STDS (NCHADS) clinics. Very few women in either cohort have ever been screened for cervical cancer. Methods After an initial educational campaign including videos and written literature, eligible women were consented and performed HPV self-sampling. HPV testing was performed with the modified AmpFire HPV isothermal testing system (Atila Biosystems, California) which provides genotyping information in following groups: 16, 18/45, 31/33/35/52/58, 39/59/68/51/56/59. All women were informed of the HPV status via SMS. All HPV positive women had digital colposcopy with 5% acetic acid using an IRIS digital colposcope (Liger, Utah) and digital images were obtained. All women hrHPV+ had ectocervical and/or endocervical biopsies with SoftBiopsy or SoftECC brush (Histologics, California). Women with CIN2+ lesions then had LEEP. Results As of October 31st, 2023, 2097 Garment workers and 530 WLWH have been enrolled. From 259 of 2097 garment workers were hrHPV+ (12.4%). 10 of the 259 (3.9%) had biopsy confirmed CIN2+ lesions. Only 9 (3.4%) of the garment workers were lost to follow up after testing positive for hrHPV. 128 of 530 WLWH were hrHPV+ (24.15%), 101 of these 128 women presented for visual evaluation of their Cervices and 21 had a CIN2+ lesions and 11 had invasive cancer. Currently, 27 of the hrHPV+ WLWH have been lost-to-follow-up, though efforts continue to reach these women. Conclusions Women in low resource settings often have great socioeconomic barriers to cervical cancer screening. Screening and treating in garment factories appears to be a very successful strategy as high numbers of women can be screened in a short period of time. Additionally, there has been very minimal loss-to-follow-up even though HPV testing was performed up to one month prior to the visual inspection of hrHPV+ women. Screening WLWH, however, is a greater challenge as they often have to travel greater distances to get screened and frequently face greater economic burdens. Strategies such as arranging and paying for all transportation and compensation for lost wages will be used in the future to limit loss-to-follow-up. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Dare Bioscience.

A Randomized Clinical Trial Comparing Visual Inspection with Acetic Acid (VIA) to Pocket Colposcopy for the Triage of HPV+ women living with HIV in Kisumu, Kenya

Evaluation of Triage Strategies for High-Risk Human Papillomavirus-Positive Women in Cervical Cancer Screening: A Multicenter Randomized Controlled Trial in Different Resource Settings in China.

Cost‐effectiveness analysis of alternative screening strategies for the detection of cervical cancer among women in rural areas of Western Kenya

The Value of Visual Inspection with Acetic Acid and Lugol's Iodine in the Screening of Cervical Cancer in the Rural Areas of China

Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial

Comparing visual inspection with acetic acid, with and without Lugols Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial

Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania

Cervical Cancer Screening Strategies for Evidence-Based Health Care Reform in China: a Multicentre, Open-Label Randomised Trial

Experiences of women participating in a human papillomavirus-based screen-triage-and treat strategy for cervical cancer prevention in Malawi

Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China A Multicenter, Open-Label, Randomized Clinical Trial

Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda

Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India

Utility of extended HPV genotyping for the triage of self-sampled HPV-positive women in a screen-and-treat strategy for cervical cancer prevention in Cameroon: a prospective study of diagnostic accuracy

Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA‐CC ANRS 12375 multicentric screening study

Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019–2020)

Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation

(114) Hpv-Automated Visual Evaluation (Pave) Study: Validating A Novel Cervical Screening Strategy. Preliminary Results Of Phase 1 From Cambodia

Screening for Early Detection of Cervical Cancer in Women Living with HIV in Mumbai, India - Retrospective Cohort Study from a Tertiary Cancer Center

HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening

Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania

Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity